Premium
Venture capitalist Eight Roads Ventures, earlier this week, announced the launch of its first India-dedicated life sciences and healthcare fund of $250 million. The venture capital firm’s healthcare investments in India include e-pharmacy platform, PharmEasy; injectable drugs manufacturer, Caplin Steriles; animal health company, Ashish Life Science, drugmaker Laurus Labs and cellular ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
